Breaking News
-
Grifols begins clinical trial of anti-SARS-CoV-2 hyperimmune globulin in patients with COVID-19
92 0Grifols, a global leader in the development of therapies with…
Read more -
Beaufond to conduct specialized trainings for managing performances in Corporate HR – Dr. Sachin Saini
101 0Beaufond PLC has initiated series of corporate programs to increase…
Read more -
COVID-19 Update. India’s tally goes to 23,29,638. 16,39,599 people in the country have recovered from the highly contagious disease, taking the recovery rate to 70.37 per cent.
101 0India”s COVID-19 tally went past 23 lakh on Wednesday with…
Read more -
COVID-19 Emergency Committee highlights need for response efforts over long term
105 0The Emergency Committee on COVID-19, convened by the WHO Director-General…
Read more -
Boehringer Ingelheim launches NexGard® and Broadline® in India for comprehensive parasite control in companion animals
161 0Boehringer Ingelheim, a leading global human pharma and animal healthcare…
Read more -
EMA’s committee issues opinion to take measures to limit presence of nitrosamines in medicines
127 0EMA’s human medicines committee (CHMP) has issued an opinion requiring…
Read more -
IDEAYA Biosciences begins patient dosing in phase 1 combination study of IDE196 and binimetinib to treat MUM
181 0IDEAYA Biosciences, an oncology-focused precision medicine company committed to the…
Read more -
NIH researchers reframe dog-to-human aging comparisons
123 0One of the most common misconceptions is that one human…
Read more -
Philip Morris gets US FDA marketing nod for IQOS tobacco heating system with ‘reduced exposure’ information
203 2The US Food and Drug Administration (FDA) authorized the marketing…
Read more -
Sedana Medical phase III study of IsoConDa meets primary endpoint
153 0Sedana Medical AB (publ), a medical device company, announced a…
Read more

